Pure Global

IVD Department quantitative C - reactive protein test - Vietnam Registration 240002092/PCBB-HN

Access comprehensive regulatory information for IVD Department quantitative C - reactive protein test in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240002092/PCBB-HN and manufactured by BEIJING STRONG BIOTECHNOLOGIES, INC.. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ CÔNG NGHỆ HKT.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240002092/PCBB-HN
Registration Details
Vietnam MOH Registration: 240002092/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department quantitative C - reactive protein test
VN: Bộ IVD xét nghiệm định lượng C - reactive protein
Risk Class TTBYT Loại B

Registration Details

240002092/PCBB-HN

000.00.19.H26-240521-0042

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

BEIJING STRONG BIOTECHNOLOGIES, INC.

Technical Details

- Quantitative C-reactive Protein (CRP) and High sensitive C-reactive Protein (HCRP) Test: Used for in vitro diagnosis to determine the concentration of C-reactive Protein in serum or plasma of humans - Calibration Standard for Quantitative C-reactive Protein (CRP) and High sensitive C-reactive Protein (HCRP) Test: This is the calibration standard of the quantitative C-reactive Protein test kit, intended for in vitro diagnosis only. - Quantitative C-reactive Protein (CRP) and High sensitive C-reactive Protein (HCRP) Control Material: This is the control material of the quantitative C-reactive Protein test kit, intended for in vitro diagnosis only.

Dates and Status

Aug 16, 2024